Products & Services · Contract with Customer, Liability
Other revenue — Contract with Customer, Liability
Moderna Other revenue — Contract with Customer, Liability increased by 11.0% to $161.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 455.2%, from $29.00M to $161.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ2 2024
Last reportedQ1 2026May 1, 2026
Rolls up toContract Liabilities
How to read this metric
An increase indicates a growing backlog of future work or deferred income, signaling potential future revenue recognition.
Detailed definition
This represents the balance of deferred revenue or performance obligations related to contracts with customers that have...
Peer comparison
Commonly referred to as deferred revenue or contract liabilities in accounting standards across the pharmaceutical and technology industries.
Metric ID:
mrna_segment_other_revenue_contract_with_customer_liabilityHistorical Data
7 periods
| Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $20.00M | $23.00M | $29.00M | $62.00M | $176.00M | $145.00M | $161.00M |
| QoQ Change | — | +15.0% | +26.1% | +113.8% | +183.9% | -17.6% | +11.0% |
| YoY Change | — | — | — | +210.0% | — | +530.4% | +455.2% |
Range$20.00M – $176.00M
CAGR+301.7%
Avg YoY Growth+398.5%
Median YoY Growth+455.2%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Moderna's other revenue — contract with customer, liability?
- Moderna (MRNA) reported other revenue — contract with customer, liability of $161.00M in Q1 2026.
- How has Moderna's other revenue — contract with customer, liability changed year-over-year?
- Moderna's other revenue — contract with customer, liability increased by 455.2% year-over-year, from $29.00M to $161.00M.
- What does other revenue — contract with customer, liability mean?
- The value of goods or services the company still owes to customers under existing contracts.